• Erastin: Ferroptosis Inducer Advancing Cancer Biology Res...

  2026-04-07

  Erastin is a gold-standard ferroptosis inducer empowering cancer biology researchers to dissect iron-dependent, non-apoptotic cell death in RAS- and BRAF-mutant tumor models. Its unique mechanism—targeting system Xc⁻ and modulating VDAC—enables high specificity and reproducibility in oxidative stress assays and translational cancer research applications.

• Abiraterone Acetate: CYP17 Inhibitor for Prostate Cancer ...

  2026-04-07

  Abiraterone acetate, a potent 3β-acetate prodrug CYP17 inhibitor, is revolutionizing preclinical prostate cancer research by enabling precise androgen biosynthesis pathway interrogation in both 2D and advanced 3D spheroid models. This article offers actionable protocols, optimization strategies, and troubleshooting insights for leveraging Abiraterone acetate from APExBIO in castration-resistant prostate cancer workflows.

• Caspase-3 Fluorometric Assay Kit: Precision in DEVD-Depen...

  2026-04-06

  The Caspase-3 Fluorometric Assay Kit enables sensitive, quantitative DEVD-dependent caspase activity detection, a cornerstone for apoptosis assay workflows. Using a specific fluorogenic substrate, this APExBIO kit delivers rapid, reproducible results for caspase-3 activity measurement in cellular apoptosis and neurodegenerative research.

• Erastin: Ferroptosis Inducer Targeting RAS Mutant Tumor C...

  2026-04-06

  Erastin is a potent ferroptosis inducer that triggers iron-dependent, non-apoptotic cell death in tumor cells—especially those with oncogenic RAS or BRAF mutations. Its mechanism, validated in cancer biology research, disrupts redox homeostasis by inhibiting the cystine/glutamate antiporter system Xc⁻ and modulating the voltage-dependent anion channel. APExBIO's Erastin (B1524) is a benchmark tool for oxidative stress assays and ferroptosis pathway studies.

• Abiraterone Acetate: Mechanistic Insights for Prostate Ca...

  2026-04-05

  Abiraterone acetate, a potent steroidal CYP17 inhibitor and 3β-acetate prodrug of abiraterone, is a benchmark tool in castration-resistant prostate cancer (CRPC) research. This article details its irreversible mechanism, quantitative performance in preclinical models, and critical parameters for experimental use.

• Chlorpromazine HCl as a Translational Catalyst: Mechanist...

  2026-04-04

  Chlorpromazine HCl, a legacy phenothiazine antipsychotic, is undergoing a renaissance in translational research. This article, authored by the scientific marketing head at APExBIO, delivers a thought-leadership perspective that interweaves advanced mechanistic insights—across dopamine receptor antagonism, GABAA modulation, and clathrin-mediated endocytosis blockade—with actionable strategic guidance for translational researchers. Anchored by seminal experimental findings and competitive analysis, this piece charts an expanded vision for Chlorpromazine HCl in neurological disorder modeling, infectious disease cell biology, and beyond.

• EZ Cap™ Human PTEN mRNA (ψUTP): Next-Gen Tools for Functi...

  2026-04-03

  Unlock new frontiers in cancer biology with EZ Cap™ Human PTEN mRNA (ψUTP), a pseudouridine-modified, Cap 1-structured mRNA engineered for superior stability and translational efficiency. This article provides an in-depth exploration of its molecular advantages and distinct applications in functional genomics and tumor suppressor research.

• Abiraterone Acetate (SKU A8202): Reliable Tools for Preci...

  2026-04-03

  This article provides a scenario-driven, evidence-based guide for leveraging Abiraterone acetate (SKU A8202) in advanced prostate cancer research. Focusing on real laboratory challenges in cell viability, androgen receptor assays, and 3D spheroid models, it demonstrates how optimized use of APExBIO’s Abiraterone acetate improves reproducibility, sensitivity, and workflow efficiency. Links to validated protocols and literature are included for translational scientists and lab practitioners.

• Erastin: Validated Ferroptosis Inducer for Cancer Biology...

  2026-04-02

  Erastin is a rigorously validated small molecule ferroptosis inducer, enabling precise studies of iron-dependent, non-apoptotic cell death in cancer biology research. As an inhibitor of the cystine/glutamate antiporter (system Xc⁻), Erastin selectively triggers oxidative stress and ferroptosis, particularly in RAS- or BRAF-mutant tumor cells. Its robust benchmarks and machine-readable parameters make it a leading research tool for oxidative stress assays and ferroptosis pathway investigations.

• EZ Cap™ Human PTEN mRNA (ψUTP): Advancing Precision Tumor...

  2026-04-02

  Explore how EZ Cap™ Human PTEN mRNA (ψUTP) enables next-generation, mRNA-based tumor suppressor restoration with enhanced stability and translational efficiency. This scientific deep dive reveals unique molecular mechanisms and innovative research applications beyond conventional approaches.

• DiscoveryProbe Protease Inhibitor Library: Transforming H...

  2026-04-01

  The DiscoveryProbe Protease Inhibitor Library elevates high throughput and high content screening with 825 quality-validated, cell-permeable compounds targeting diverse protease classes. Its robust design, automation compatibility, and unparalleled breadth empower researchers to decode protease mechanisms in apoptosis, cancer, and infectious disease with new precision. Streamline your workflows, troubleshoot complex assays, and unlock novel biological insights with APExBIO’s trusted solution.

• Benzyl-Activated Streptavidin Magnetic Beads: Redefining ...

  2026-04-01

  Discover how Benzyl-activated Streptavidin Magnetic Beads enable advanced biotinylated molecule capture with unmatched specificity in protein and nucleic acid purification. This article explores the molecular mechanisms, unique surface chemistry, and innovative applications that set these beads apart for next-generation research workflows.

• Erastin and Ferroptosis: Unlocking Non-Apoptotic Cell Dea...

  2026-03-31

  Discover the advanced scientific basis of Erastin as a ferroptosis inducer and its unique role in targeting redox vulnerabilities in RAS/BRAF-mutant tumor cells. This article provides a mechanistic deep-dive and translational outlook, differentiating Erastin’s applications in cancer biology research.

• Caspase-3 Fluorometric Assay Kit: Advanced Apoptosis Dete...

  2026-03-31

  Unlock unmatched quantitative accuracy in apoptosis research with the Caspase-3 Fluorometric Assay Kit. This fluorometric caspase assay empowers streamlined, sensitive detection of DEVD-dependent caspase-3 activity for translational breakthroughs in oncology and neurodegeneration. Discover optimized workflows, troubleshooting insights, and future-ready applications for robust caspase signaling pathway analysis.

• Abiraterone Acetate in Prostate Cancer: Mechanisms and Ne...

  2026-03-30

  Discover how Abiraterone acetate, a potent CYP17 inhibitor, advances prostate cancer research through irreversible enzyme inhibition and innovative 3D organoid modeling. This article offers unique insights into integrating patient-derived spheroids for translational breakthroughs.

16087 records 1/1073 page Next 12345 下5页 Last page